Anti-C-kit (CD117) [1C8]
Invented at A*STAR Accelerate Technologies Pte Ltd
- Datasheet
- References (2)
- Inventor Info
Info
![Image thumbnail for Anti-C-kit (CD117) [1C8]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/e8d6cd15-6c6c-41f9-ac07-7208ac656821.jpg)
![Image thumbnail for Anti-C-kit (CD117) [1C8]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/b52a4cd2-e502-4f39-93c5-bd19f57784fe.jpg)
| Catalogue Number | 153478 |
| Applications | FACS WB |
| Antigen/Gene or Protein Targets | C-kit |
| Synonyms | C Kit antibody, c-Kit antibody, CD117 antibody |
| Reactivity | Human |
| Relevance | C-kit, also known as CD117, is expressed on the surface of hematopoietic stem cells. C-kit is a receptor tyrosine kinase that is overexpressed in > 70% of gastrointestinal stromal tumors (GISTs). |
| Host | Mouse |
| Immunogen | GST-fusion protein containing 315-519 residues of human c-kit. c-kit. This region is in the extracellular domain of c-kit. |
| Subclass | IgG1 |
| Myeloma Used | Sp2/0-Ag14 |
| Strain | Balb/c |
| Research Area | Cancer, Immunology |
References: 2 entries
Bellone et al. 2001. Cancer Res. 61(5):2200-6. PMID: 11280787.
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.
Europe PMC ID: 11280787
Add a reference
References: 2 entries
Bellone et al. 2001. Cancer Res. 61(5):2200-6. PMID: 11280787.
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.
Add a reference
